Health outcomes for diverse populations are worse across all health conditions. While healthcare organizations and clinicians should consider social determinants of health (SDOH) when providing care, this approach has not demonstrated improvements in overall health outcomes. To deal with health equity we must address the systemic clinical bias that exists in medicine. As examples, diverse populations receive lower doses of pain medications, reduced recommendations for surgical procedures, marginal participation in clinical trials, pre-screening for chronic conditions at lower rates, and are subject to race corrections in calculators and diagnostics that are not medically substantiated. Identifying these issues, creating clinician awareness, and making them actionable at the point of care are critical to reducing health disparities.
We have made great progress on our three key areas of focus – accelerating our commercial activities, enhancement of our product for providers and patients, and analysis and validation of our impact. During our live sessions the experts at Mayo and ASU provided great insight and advice. We’ve been able to tailor a follow-up project plan to extend the value of our relationship well past the bootcamp.
"The collaborative experience with the Mayo Clinic, Arizona State University ASU and the peer companies far exceeded our expectations."
Alan Roga
MD, CEO